Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Augusto Bleve
Observed names:
Bleve Augusto,
Bleve, Augusto
Institutions:
Mario Negri Institute for Pharmacological Research,
IRCCS Humanitas Research Hospital
Observed institutions:
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”,
Mario Negri Institute for Pharmacological Research,
IRCCS Humanitas Research Hospital,
University of Pennsylvania,
University of Gothenburg
ORCID:
0000-0003-1585-4722
Observed ORCID:
0000-0003-1585-4722
OpenAlex ID:
A5021701467
Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases
2022
·
Augusto Bleve
, Francesca Motta
, et al.
·
Clinical Reviews in Allergy & Immunology
·
204
PDF
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs
2020
·
Chiara Porta
, Francesca Maria Consonni
, et al.
·
Cancer Research
·
151
PDF
Heme catabolism by tumor-associated macrophages controls metastasis formation
2021
·
Francesca Maria Consonni
, Augusto Bleve
, et al.
·
Nature Immunology
·
130
Insulin-Driven PI3K-AKT Signaling in the Hepatocyte Is Mediated by Redundant PI3Kα and PI3Kβ Activities and Is Promoted by RAS
2019
·
Angela Molinaro
, Barbara Becattini
, et al.
·
Cell Metabolism
·
118
PDF
Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
2019
·
Francesca Maria Consonni
, Chiara Porta
, et al.
·
Frontiers in Immunology
·
116
PDF
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
2020
·
Augusto Bleve
, Barbara Durante
, et al.
·
International Journal of Molecular Sciences
·
111
PDF
Metabolic influence on the differentiation of suppressive myeloid cells in cancer
2018
·
Chiara Porta
, Arianna Marino
, et al.
·
Carcinogenesis
·
32
RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
·
Cancer Discovery
·
29
PDF
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment
2025
·
Ersilia Varone
, Michele Retini
, et al.
·
Cell Death and Disease
·
25
PDF
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy
2024
·
Gloriana Ndembe
, Ilenia Intini
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
24
PDF
Membrane Cholesterol Regulates Macrophage Plasticity in Cancer
2019
·
Antonio Sica
, Augusto Bleve
, et al.
·
Cell Metabolism
·
22
PDF
Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective
2022
·
Augusto Bleve
, Francesca Maria Consonni
, et al.
·
Cancers
·
21
PDF
Immunometabolic interference between cancer and COVID-19
2023
·
Francesca Maria Consonni
, Barbara Durante
, et al.
·
Frontiers in Immunology
·
3
Data from Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs
2023
·
Chiara Porta
, Francesca Maria Consonni
, et al.
·
1
Targeting ERO1α triggers tumor immunosurveillance in triple-negative breast cancer
2026
·
Alessandro Cherubini
, Ersilia Varone
, et al.
·
Redox Biology
787 RORγ bridges cancer-driven lipid dysmetabolism and myeloid immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Ablation of ERO1α Activates Anti-Tumor Immunity in Breast Cancer
2025
·
Ester Zito
, Alessandro Cherubini
, et al.
·
Free Radical Biology and Medicine
Figure S10 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S8 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S3 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S1 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S2 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Data from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
Table S2 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S7 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Show more works
View as search
Works count:
45
Citation count:
985
H-index:
12
I10-index:
12
Year
Topic
Type